Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: acvr1bb ENSDARG00000052142

.

Description

activin A receptor type 1Bb [Source:ZFIN;Acc:ZDB-GENE-131120-9]

Gene Synonyms

sb:eu632, si:zfos-824d4.1

Location

Chromosome 6: 2,174,082-2,198,683 forward strand.

GRCz11:CM002890.2

About this gene

This gene has 3 transcripts (splice variants), 78 orthologues and 20 paralogues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSDART00000073936.6	acvr1bb-201	1789	498aa	ENSDARP00000068426.5	Gene/transcipt that contains an open reading frame (ORF).Protein coding	F1QZF0	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSDART00000156716.3	acvr1bb-203	1502	493aa	ENSDARP00000129240.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	X1WG85	3' truncation in transcript evidence prevents annotation of the end of the CDS.CDS 3' incomplete,
ENSDART00000155659.2	acvr1bb-202	446	86aa	ENSDARP00000127809.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	X1WC66	5' truncation in transcript evidence prevents annotation of the start of the CDS.CDS 5' incomplete,

.

Summary

.

.